Question 1

Who are the top researchers at NanoCarrier (Japan)?

Accepted Answer

Ranked on the quality score, Mitsunori Harada, Kenichiro Naito and Atsuhiro Masada lead among researchers whose main affiliation is NanoCarrier (Japan).

Question 2

What are the most cited papers from NanoCarrier (Japan)?

Accepted Answer

The most cited paper from NanoCarrier (Japan) is "Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice." (Nobuhiro Nishiyama, Souichiro Okazaki, Horacio Cabral et al., 2003), with 602 citations. Next come "NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel" (563) and "Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats" (428).

Question 3

Which research topics does NanoCarrier (Japan) publish most on?

Accepted Answer

By volume in 2022-now: Shape Memory Alloy Transformations, RNA Interference and Gene Delivery, Supercapacitor Materials and Fabrication and Pancreatic and Hepatic Oncology Research.

Question 4

Which keywords describe research at NanoCarrier (Japan)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Nanoparticles, Tumor Targeting, Biomedical Applications, Drug Delivery, Cancer Therapy, Nanocarriers, Surface Engineering and Chemotherapy.

Question 5

Which fields of science does NanoCarrier (Japan) work in?

Accepted Answer

In all years, 36% of research at NanoCarrier (Japan) is in Health Sciences, 35% in Physical Sciences. Its largest fields are Medicine (36%), Materials Science (22%), Biochemistry, Genetics and Molecular Biology (14%). It does 1.5× the world's share of Life Sciences.

Question 6

Is NanoCarrier (Japan)'s research output growing?

Accepted Answer

Output in 2022-2025 was 44% lower than in 2018-2021.